Protagonist Therapeutics

PTGX

Market cap $5.42B

Upgrade to unlock

Buy

Hold

Sell

9 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

Avg. target

$86

0% upside

High target

9 analyst ratings

positive

0 neutral

0%

negative

Analyst & Firm	Rating	Price Target	Upside Downside	Date
Citigroup Geoff Meacham 100% 1-yr PTGX win rate				10 Nov ‘25 21 days ago
JP Morgan Brian Cheng 100% 1-yr PTGX win rate				7 Nov ‘25 24 days ago
Barclays Etzer Darout 100% 1-yr PTGX win rate				7 Nov ‘25 24 days ago
Citizens Jonathan Wolleben 100% 1-yr PTGX win rate				7 Nov ‘25 24 days ago
Truist Securities Srikripa Devarakonda 100% 1-yr PTGX win rate				28 Oct ‘25 1 month ago
Wedbush Yun Zhong 100% 1-yr PTGX win rate				28 Oct ‘25 1 month ago
BTIG Julian Harrison 100% 1-yr PTGX win rate				28 Oct ‘25 1 month ago
HC Wainwright & Co Douglas Tsao 73% 1-yr PTGX win rate				8 Oct ‘25 1 month ago
Leerink Partners Faisal Khurshid 100% 1-yr PTGX win rate				12 Sep ‘25 2 months ago